In the latest class action loss, a judge has said that $165 million in fees charged to members by NAB super fund trustee NULIS Nominees was corporate revenue “with which it was free to deal as it saw fit”.
A class action against NAB unit NULIS Nominees over adviser fees charged to superannuation fund members should be dismissed, a judge has found.
Law firm Gerard Malouf & Partners will move for a solicitors’ common fund order in a class action against Philips Electronics, which will give it an effective contingency fee in the event of a win or settlement.
The High Court has upheld appeals in class actions against Ford and Toyota over the calculation of damages for reduction in value of defective vehicles.
Over objections from the ACCC, a judge has struck out the regulator’s entire case against Meta over scam cryptocurrency ads on Facebook after it clarified that each allegedly misleading ad should be a separate contravention.
Michael Hill has won its challenge to a decision that found the jewellery retailer breached an exclusivity clause and minimum order requirements in a sales agreement with a packaging supplier.
The consumer regulator must identify the advertisements it relies on to prove its case against Meta over scam cryptocurrency ads on Facebook, with a judge saying the social media giant should know the case it has to meet.
The High Court has granted special to leave to a class action against Ford over allegedly PowerShift transmissions, agreeing to hear the case alongside two appeals in a class action against Toyota that deal with how reduction in value damages should be calculated under the Australian Consumer Law.
The High Court has been asked to hear another case dealing with how reduction in value damages should be calculated under the Australian Consumer Law, with Ford arguing its appeal should be heard alongside two appeals in a class action against Toyota which the High Court has already agreed to take up.
The High Court has agreed to weigh in on a 16-year battle between the federal government and French drug maker Sanofi-Aventis over an allegedly unjustified court order that prevented the release of a generic version of blockbuster blood-thinner Plavix.